Peroxisome-proliferator-activated receptor-gamma agonists inhibit the release of proinflammatory cytokines from RSV-infected epithelial cells (Q40343418)

From Wikidata

Jump to navigation Jump to search

scientific article published on 5 December 2005

Language	Label	Description	Also known as
English	Peroxisome-proliferator-activated receptor-gamma agonists inhibit the release of proinflammatory cytokines from RSV-infected epithelial cells	scientific article published on 5 December 2005

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

Peroxisome-proliferator-activated receptor-gamma agonists inhibit the release of proinflammatory cytokines from RSV-infected epithelial cells (English)

1 reference

Europe PubMed Central

19 September 2017

author name string

Ralf Arnold

1

1 reference

Europe PubMed Central

19 September 2017

Wolfgang König

2

1 reference

Europe PubMed Central

19 September 2017

language of work or name

0 references

publication date

5 December 2005

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

346

1 reference

Europe PubMed Central

19 September 2017

2

1 reference

Europe PubMed Central

19 September 2017

427-439

1 reference

Europe PubMed Central

19 September 2017

Pathological changes in virus infections of the lower respiratory tract in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Respiratory syncytial virus infection of human lung endothelial cells enhances selectively intercellular adhesion molecule-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Cetirizine counter-regulates interleukin-8 release from human epithelial cells (A549)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Respiratory syncytial virus deficient in soluble G protein induced an increased proinflammatory response in human lung epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Regulation of peroxisome proliferator-activated receptor gamma expression in human asthmatic airways: relationship with proliferation, apoptosis, and airway remodeling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

PPAR-gamma agonists as therapy for diseases involving airway neutrophilia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-kappa B and is inhibited by sodium salicylate and aspirin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Microplaque immunoperoxidase detection of infectious respiratory syncytial virus in the lungs of infected mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Requirement of a novel upstream response element in respiratory syncytial virus-induced IL-8 gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Multiple cis regulatory elements control RANTES promoter activity in alveolar epithelial cells infected with respiratory syncytial virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Activation of vascular endothelial cells by IL-1α released by epithelial cells infected with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathw

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

RANTES may be predictive of later recurrent wheezing after respiratory syncytial virus bronchiolitis in infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Transcriptional activation of alpha/beta interferon genes: interference by nonsegmented negative-strand RNA viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

The steroid and thyroid hormone receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Epithelial regulation of innate immunity to respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Effect of rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 on bleomycin-induced lung injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Respiratory syncytial virus and parainfluenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Expression of peroxisome proliferator-activated receptors in human testicular cancer and growth inhibition by its agonists

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Peroxisome proliferator-activated receptor gamma agonists inhibit HIV-1 replication in macrophages by transcriptional and post-transcriptional effects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Peroxisome proliferator-activated receptor gamma is expressed in airways and inhibits features of airway remodeling in a mouse asthma model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Severity of respiratory syncytial virus disease related to type and genotype of virus and to cytokine values in nasopharyngeal secretions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Cytokines and chemokines in respiratory secretion and severity of disease in infants with respiratory syncytial virus (RSV) infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Management of respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Treatment and prevention of respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Activator protein-1 is the preferred transcription factor for cooperative interaction with nuclear factor-kappaB in respiratory syncytial virus-induced interleukin-8 gene expression in airway epithelium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Pro- and anti-inflammatory responses in respiratory syncytial virus bronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Chemokines and inflammation in the nasal passages of infants with respiratory syncytial virus bronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

HIV-1 Nef protein in the nucleus influences adipogenesis as well as viral transcription through the peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Autocrine regulation of interleukin-8 by interleukin-1alpha in respiratory syncytial virus-infected pulmonary epithelial cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Molecular basis for the direct inhibition of AP-1 DNA binding by 15-deoxy-Delta 12,14-prostaglandin J2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Respiratory syncytial virus M2-1 protein induces the activation of nuclear factor kappa B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Troglitazone Antagonizes Tumor Necrosis Factor-α-induced Reprogramming of Adipocyte Gene Expression by Inhibiting the Transcriptional Regulatory Functions of NF-κB

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Prolonged production of TNF-alpha exacerbates illness during respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Stimulation of peroxisome proliferator-activated receptors alpha and gamma blocks HIV-1 replication and TNFalpha production in acutely infected primary blood cells, chronically infected U1 cells, and alveolar macrophages from HIV-infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Respiratory syncytial virus bronchiolitis: disease severity, interleukin-8, and virus genotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

17beta-estradiol inhibition of NADPH oxidase expression in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Peroxisome proliferator-activated receptor-gamma regulates airway epithelial cell activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Beta-chemokines, but neither T helper type 1 nor T helper type 2 cytokines, correlate with severity of illness during respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

ICAM-1 expression and low-molecular-weight G-protein activation of human bronchial epithelial cells (A549) infected with RSV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

based on heuristic

inferred from DOI database lookup

Transcriptional activation of the interleukin-8 gene by respiratory syncytial virus infection in alveolar epithelial cells: nuclear translocation of the RelA transcription factor as a mechanism producing airway mucosal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

based on heuristic

inferred from DOI database lookup

Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.009

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2005.11.009

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40343418&oldid=1895765430"